TWO SIGMA INVESTMENTS, LP - INNATE PHARMA S A ownership

Back to all holdings Add to watchlist

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 19 filers reported holding INNATE PHARMA S A in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2022$38,000
-44.1%
18,789
-25.7%
0.00%–
Q2 2022$68,000
-43.8%
25,289
-29.9%
0.00%–
Q1 2022$121,000
-60.5%
36,089
-46.2%
0.00%
-100.0%
Q4 2021$306,000
+163.8%
67,055
+256.1%
0.00%–
Q3 2021$116,000–18,829–0.00%–
 Download
Other shareholders
INNATE PHARMA S A shareholders Q3 2021
NameSharesValueWeighting ↓
BANK OF AMERICA CORP /DE/ 46,749$133,2350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 61,899$1760.00%
MORGAN STANLEY 48,722$138,8580.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,315$37,8150.00%
Steward Partners Investment Advisory, LLC 500$1,4250.00%
Optiver Holding B.V. 224,097$636,4350.00%
BARCLAYS PLC 412$10.00%
ROYAL BANK OF CANADA 124$00.00%
UBS Group AG 1,259$3,5880.00%
View complete list of INNATE PHARMA S A shareholders